What's new in the treatment of seminomas?

被引：1

作者：

Boujelbene, N. ^{[1
]}

Ozsahin, M. ^{[1
]}

Khanfir, K. ^{[2
]}

Azria, D. ^{[3
,4
]}

Mirimanoff, R. O. ^{[1
]}

Zouhair, A. ^{[1
]}

机构：

[1] CHU Vaudois, Serv Radiooncol, CH-1011 Lausanne, Switzerland

[2] Hop Sion, Serv Radiooncol, CH-1952 Sion, Switzerland

[3] CRLC Val dAurelle Paul Lamarque, Serv Radiooncol, F-34298 Montpellier 5, France

[4] Univ Montpellier I, F-34967 Montpellier 2, France

来源：

CANCER RADIOTHERAPIE | 2011年 / 15卷 / 03期

关键词：

Seminoma; Treatment; Radiotherapy; Chemotherapy; Surveillance; STAGE-I SEMINOMA; SINGLE-AGENT CARBOPLATIN; GERM-CELL TUMORS; SURVEILLANCE FOLLOWING ORCHIECTOMY; EUROPEAN CONSENSUS CONFERENCE; POSITRON-EMISSION-TOMOGRAPHY; HUMAN CHORIONIC-GONADOTROPIN; CISPLATIN-BASED CHEMOTHERAPY; TESTICULAR SEMINOMA; PROGNOSTIC-FACTORS;

D O I：

10.1016/j.canrad.2010.09.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Pure testicular seminoma is a rare disease with an excellent prognosis. Its management is controversial. In stage I disease, several treatment options are considered. Those are radiation therapy alone, chemotherapy alone or active surveillance, which is becoming increasingly popular. For more advanced stages, treatment is based on chemotherapy with or without radiation therapy. In this article, we review thoroughly the existing literature and recent recommendations the various treatment options, their advantages and disadvantages in different stages of the disease. (C) 2010 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

引用

页码：208 / 220

页数：13

共 158 条

[1] RADIATION-THERAPY OF TESTICULAR SEMINOMA - A 15-YEAR SURVEY [J].

ABDEEN, N ;

SOUHAMI, L ;

FREEMAN, C ;

YASSA, M ;

ROMAN, T .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (01) :87-90

[2]

*AJCC, 2002, CANC STAG MAN, P317

[3] The preferred treatment for stage I seminoma: A survey of Canadian radiation oncologists [J].

Alomary, I. ;

Samant, R. ;

Genest, P. ;

Eapen, L. ;

Gallant, V. .

CLINICAL ONCOLOGY, 2006, 18 (09) :696-699

[4] TESTICULAR SEMINOMA - RESULTS OF A PROGRAM OF MEGAVOLTAGE IRRADIATION [J].

ANDREWS, CF ;

MICAILY, B ;

BRADY, LW .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (06) :491-495

[5]

[Anonymous], 2021, PLYM M PA

[6] Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma [J].

Aparicio, J ;

del Muro, XG ;

Maroto, P ;

Paz-Ares, L ;

Alba, E ;

Sáenz, A ;

Terrasa, J ;

Barnadas, A ;

Almenar, D ;

Arranz, JA ;

Sánchez, M ;

Fernández, A ;

Sastre, J ;

Carles, J ;

Dorca, J ;

Gumà, J ;

Yuste, AL ;

Germà, JR .

ANNALS OF ONCOLOGY, 2003, 14 (06) :867-872

[7] Risk-adapted management for patients with clinical stage I seminoma:: The second Spanish germ cell cancer cooperative group study [J].

Aparicio, J ;

Germà, JR ;

del Muro, XG ;

Maroto, P ;

Arranz, JA ;

Sáenz, A ;

Barnadas, A ;

Dorca, J ;

Gumà, J ;

Olmos, D ;

Bastús, R ;

Carles, J ;

Almenar, D ;

Sánchez, M ;

Paz-Ares, L ;

Satrústegui, JJ ;

Mellado, B ;

Balil, A ;

López-Brea, M ;

Sánchez, A .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8717-8723

[8]

Argirovic Dj, 2005, J BUON, V10, P195

[9] E400P in advanced seminoma of good prognosis according to the International Germ Cell Cancer Collaborative Group (IGCCCG) classification:: The Spanish Germ Cell Cancer Group experience [J].

Arija, JAA ;

del Muro, XG ;

Gumà, J ;

Aparicio, J ;

Salazar, R ;

Saenz, A ;

Carles, J ;

Sánchez, M ;

Germà-Lluch, JR .

ANNALS OF ONCOLOGY, 2001, 12 (04) :487-491

[10]

ARLEN M, 1971, CANCER-AM CANCER SOC, V28, P1087, DOI 10.1002/1097-0142(1971)28:5<1087::AID-CNCR2820280502>3.0.CO

← 1 2 3 4 5 6 7 8 9 10 →